Ibnsina Pharma (EGX:ISPH)

Ibnsina Pharma Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	12,046	11,814	7,056	3,165	2,419	3,907
Market Cap Growth	24.74%	67.43%	122.93%	30.83%	-38.08%	-20.04%
Enterprise Value	37,743	35,439	23,168	15,142	11,020	10,960
Last Close Price	11.95	11.58	6.82	3.06	2.11	3.20
PE Ratio	15.62	15.32	14.17	18.28	17.84	13.65
Forward PE	7.81	8.77	11.62	10.44	3.90	9.83
PS Ratio	0.16	0.15	0.13	0.09	0.11	0.18
PB Ratio	4.33	4.24	3.47	2.18	1.92	2.69
P/TBV Ratio	4.73	4.64	3.89	2.57	1.97	2.72
P/OCF Ratio	-	-	-	25.16	6.69	-
PEG Ratio	0.24	0.19	0.26	0.35	0.35	0.41
EV/Sales Ratio	0.49	0.46	0.42	0.45	0.50	0.50
EV/EBITDA Ratio	9.77	9.54	9.69	11.96	18.48	13.97
EV/EBIT Ratio	10.66	10.01	10.26	13.15	22.85	16.42
Debt / Equity Ratio	9.58	9.58	9.94	9.06	7.82	5.49
Debt / EBITDA Ratio	6.91	6.91	8.08	9.83	14.82	9.47
Net Debt / Equity Ratio	9.23	9.23	9.53	8.28	7.39	5.17
Net Debt / EBITDA Ratio	6.92	6.92	8.10	9.48	15.62	9.57
Net Debt / FCF Ratio	-31.90	-31.90	-16.31	-52.59	-21.33	-15.39
Asset Turnover	2.36	2.36	2.37	2.16	1.84	2.12
Inventory Turnover	9.47	9.47	10.53	10.82	8.30	9.02
Quick Ratio	0.71	0.71	0.67	0.68	0.60	0.66
Current Ratio	1.02	1.02	1.00	1.00	1.00	1.03
Return on Equity (ROE)	39.54%	39.54%	35.32%	15.75%	12.60%	22.31%
Return on Assets (ROA)	6.83%	6.83%	5.98%	4.58%	2.50%	4.06%
Return on Invested Capital (ROIC)	11.46%	12.55%	11.32%	7.63%	4.81%	5.87%
Return on Capital Employed (ROCE)	79.00%	79.00%	70.20%	43.90%	20.10%	35.40%
Earnings Yield	6.40%	8.06%	8.71%	6.75%	7.13%	8.05%
FCF Yield	-6.69%	-6.82%	-16.82%	-7.21%	-18.05%	-12.49%
Dividend Yield	1.34%	-	2.34%	-	-	2.69%
Payout Ratio	37.91%	21.12%	4.17%	10.74%	81.35%	4.63%
Buyback Yield / Dilution	-	-	-	-	22.58%	-16.25%
Total Shareholder Return	1.34%	-	2.34%	-	22.58%	-13.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.